Eamonn Murphy Email & Phone Number

Bogota, Nj, Us

Bedminster, New Jersey, Us

Tel-Aviv, Il

• Managed and aligned the legacy Actavis Americas Elemental Impurities compliance project with the Teva standard. Managed the Elemental Impurities laboratory network (four labs) and program for Actavis commercial product. Project scope included fifteen sites globally with a central lab staff of fourteen scientists and technicians. Successfully completed method validation and screening for a total of four hundred products to demonstrate compliance with new regulatory requirement • Provided expert analytical method and product investigation support to Teva domestic sites. Several critical method issues and technical investigations were resolved resulting in uninterrupted supply of critical product to the market

Dublin, Coolock, Ie

• Managed the Actavis Americas Elemental Impurities compliance project. Coordinated project scope and managed the Elemental Impurities laboratory network (four labs) and program for Actavis commercial product. Project scope included fifteen sites globally with a central lab staff of fourteen scientists and technicians. Successfully completed method validation and screening for two hundred products to demonstrate compliance with new regulatory requirement • Managed analytical GMP lab group to support investigation and compliance based projects at the Elizabeth, NJ site. • Provided expert analytical method and product investigation support to domestic sites. Several critical method issues and technical investigations were resolved resulting in uninterrupted supply of critical product to the market• Managed commercial product method remediation at Actavis Elizabeth, NJ ensuring key commercial products supply to customer• Subject Matter Expert for Third Party Operations on method enhancement projects for compliance of drug products with current ICH guidelines• Reinforced organization compliance and quality culture with FDA inspectors by addressing FDA inspection queries, drafting 483 deficiency responses and providing expert input for field alert investigations. • Mentored and developed team of ten scientists to establish and maintain an efficient expert analytical lab group

Dublin, Ie

• Established and managed a GMP lab and expert analytical lab group to support investigation and compliance based projects at the Elizabeth site • In 2013-2014, designed and implemented the Actavis Americas Elemental Impurities compliance project. Established and managed the Elemental Impurities laboratory network (four labs) and program for Actavis Americas commercial product. Project scope included fifteen sites globally with a central lab staff of fourteen scientists and technicians. • Provided expert analytical method and product investigation support to three domestic sites. Several critical method issues and technical investigations were resolved resulting in uninterrupted supply of critical product to the market• Managed commercial product method remediation at Actavis Elizabeth, NJ and Lincolnton, NC sites from 2010 onwards ensuring key commercial products supply to customer• Subject Matter Expert for Third Party Operations on method enhancement projects for compliance of drug products with current ICH guidelines• Reinforced organization compliance and quality culture with FDA inspectors by addressing FDA inspection queries, drafting 483 deficiency responses and providing expert input for field alert investigations. • Mentored and developed team of six scientists to establish an efficient expert analytical lab group. Group increased to ten scientists by 2015. • From 2012 onward, responsible for the assessment of API Supplier Change Notifications / DMF Updates (10-12 per year) for the Actavis Elizabeth NJ site

• Lead on method remediation project for two product re-introductions under consent. Product re-introductions were key commercial successes for site• Provided expert analytical method and product investigation support. Several critical method issues and technical investigations were resolved resulting in uninterrupted supply of critical product to the market• Managed internal Actavis lab with two resources for investigation support through identification of impurities by HPLC mass spectrometry. Prompt identification ensured uninterrupted market supply of product

Dublin, Ie

• Provided expert analytical method and product investigation support to site. Several critical method issues and technical investigations were resolved resulting in uninterrupted supply of critical product to the market• Managed commercial product method remediation ensuring key commercial products supply to customer• Established and managed an internal Actavis lab with two resources for investigation support through identification of impurities by HPLC mass spectrometry. Prompt identification ensured uninterrupted market supply of product

• Supervised GLP projects with three direct report chemists in the characterization of primary reference standards for drug substance and impurities for Novartis Animal Healthcare in Basel• Liaised with Novartis Animal Healthcare, Carbogen AG Management, Quality, and R&D chemist group to ensure timely completion of projects within budget• Authored characterization protocols, reports, documentation for reference standard characterization• Responsible for administration of characterization/recertification, documentation and storage of standards at Carbogen AG, and international distribution of standards for Novartis Animal Healthcare, Basel• Interpreted and reported on non-routine external CRO and internal analytical data including pyrolysis-GC-MS and multinuclear NMR experiments, as examples, for investigation support• Operated in a GMP compliant paperless lab environment with SQL LIMS

Dublin, Oh, Us

Zürich, Ch

Göttingen, Niedersachsen, De